Adalimumab in the treatment of refractory non-infectious scleritis: 6-month outcomes

Authors
Category Primary study
JournalInvestigative Ophthalmology and Visual Science
Year 2023
This article has no abstract
Epistemonikos ID: 86e2e6796e26735ac4bb3e6f83ef74a93453be22
First added on: Feb 16, 2025